Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Weaver

Showing results (671-680 of 673) with videos related to

Pageof 68
Sort By:
You have reached the last page of results.This site can display upto 673 results.
Contemporary Clinical Trials|June 17, 2018
Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency managementN Metrebian, T Weaver, S Pilling, et al.
Elife|September 4, 2019
FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapyCarlos J Diaz Osterman, Duygu Ozmadenci, Elizabeth G Kleinschmidt, et al.
Nature Reviews. Immunology|November 18, 2025
Guidelines for T cell nomenclatureDavid Masopust, Amit Awasthi, Rémy Bosselut, et al.
Pageof 68

Showing results (671-680 of 673) with videos related to

Sort By:
Pageof 68
You have reached the last page of results.This site can display upto 673 results.
Contemporary Clinical Trials|June 17, 2018
Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency managementN Metrebian, T Weaver, S Pilling, et al.
Elife|September 4, 2019
FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapyCarlos J Diaz Osterman, Duygu Ozmadenci, Elizabeth G Kleinschmidt, et al.
Nature Reviews. Immunology|November 18, 2025
Guidelines for T cell nomenclatureDavid Masopust, Amit Awasthi, Rémy Bosselut, et al.
Pageof 68